Revvity ROA 2012-2026 | RVTY
Current and historical return on assets (ROA) values for Revvity (RVTY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Revvity ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-06-30 | $0.24B | $12.09B | 1.97% |
| 2026-03-31 | $0.24B | $12.17B | 1.97% |
| 2025-12-31 | $0.24B | $12.26B | 1.97% |
| 2025-09-30 | $0.24B | $12.31B | 1.93% |
| 2025-06-30 | $0.29B | $12.47B | 2.29% |
| 2025-03-31 | $0.29B | $12.74B | 2.25% |
| 2024-12-31 | $0.27B | $13.01B | 2.08% |
| 2024-09-30 | $0.25B | $13.30B | 1.91% |
| 2024-06-30 | $0.17B | $13.46B | 1.26% |
| 2024-03-31 | $0.15B | $13.66B | 1.10% |
| 2023-12-31 | $0.69B | $13.96B | 4.96% |
| 2023-09-30 | $0.74B | $14.10B | 5.26% |
| 2023-06-30 | $0.82B | $14.20B | 5.76% |
| 2023-03-31 | $0.96B | $14.20B | 6.77% |
| 2022-12-31 | $0.57B | $14.25B | 3.99% |
| 2022-09-30 | $0.63B | $14.47B | 4.36% |
| 2022-06-30 | $0.67B | $14.74B | 4.57% |
| 2022-03-31 | $0.74B | $13.37B | 5.54% |
| 2021-12-31 | $0.94B | $11.85B | 7.96% |
| 2021-09-30 | $1.13B | $10.09B | 11.23% |
| 2021-06-30 | $1.18B | $8.08B | 14.63% |
| 2021-03-31 | $1.07B | $7.56B | 14.20% |
| 2020-12-31 | $0.73B | $6.96B | 10.46% |
| 2020-09-30 | $0.41B | $6.61B | 6.25% |
| 2020-06-30 | $0.30B | $6.51B | 4.53% |
| 2020-03-31 | $0.23B | $6.45B | 3.52% |
| 2019-12-31 | $0.23B | $6.38B | 3.57% |
| 2019-09-30 | $0.23B | $6.24B | 3.75% |
| 2019-06-30 | $0.25B | $6.08B | 4.14% |
| 2019-03-31 | $0.25B | $5.97B | 4.14% |
| 2018-12-31 | $0.24B | $5.98B | 3.98% |
| 2018-09-30 | $0.13B | $6.01B | 2.10% |
| 2018-06-30 | $0.14B | $5.73B | 2.44% |
| 2018-03-31 | $0.28B | $5.39B | 5.19% |
| 2017-12-31 | $0.29B | $4.94B | 5.93% |
| 2017-09-30 | $0.40B | $4.49B | 8.89% |
| 2017-06-30 | $0.37B | $4.38B | 8.35% |
| 2017-03-31 | $0.23B | $4.28B | 5.28% |
| 2016-12-31 | $0.23B | $4.25B | 5.51% |
| 2016-09-30 | $0.24B | $4.22B | 5.62% |
| 2016-06-30 | $0.23B | $4.15B | 5.64% |
| 2016-03-31 | $0.22B | $4.12B | 5.31% |
| 2015-12-31 | $0.21B | $4.08B | 5.20% |
| 2015-09-30 | $0.18B | $4.07B | 4.30% |
| 2015-06-30 | $0.16B | $4.03B | 4.02% |
| 2015-03-31 | $0.16B | $4.00B | 4.08% |
| 2014-12-31 | $0.16B | $3.98B | 3.94% |
| 2014-09-30 | $0.19B | $3.94B | 4.90% |
| 2014-06-30 | $0.19B | $3.93B | 4.86% |
| 2014-03-31 | $0.17B | $3.90B | 4.34% |
| 2013-12-31 | $0.17B | $3.86B | 4.33% |
| 2013-09-30 | $0.08B | $3.84B | 2.19% |
| 2013-06-30 | $0.07B | $3.85B | 1.92% |
| 2013-03-31 | $0.08B | $3.85B | 2.08% |
| 2012-12-31 | $0.07B | $3.86B | 1.84% |
| 2012-09-30 | $0.00B | $3.85B | 0.08% |
| 2012-06-30 | $0.01B | $3.73B | 0.27% |
| 2012-03-31 | $0.01B | $3.68B | 0.16% |
| 2011-12-31 | $0.01B | $3.54B | 0.23% |
| 2011-09-30 | $0.39B | $3.38B | 11.49% |
| 2011-06-30 | $0.36B | $3.34B | 10.90% |
| 2011-03-31 | $0.39B | $3.23B | 12.15% |
| 2010-12-31 | $0.39B | $3.16B | 12.38% |
| 2010-09-30 | $0.13B | $3.12B | 4.20% |
| 2010-06-30 | $0.13B | $3.07B | 4.30% |
| 2010-03-31 | $0.10B | $3.02B | 3.18% |
| 2009-12-31 | $0.08B | $2.98B | 2.78% |
| 2009-09-30 | $0.08B | $2.95B | 2.65% |
| 2009-06-30 | $0.12B | $2.94B | 3.95% |
| 2009-03-31 | $0.12B | $2.97B | 3.97% |
| 2008-12-31 | $0.13B | $3.03B | 4.20% |
| 2008-09-30 | $0.15B | $3.03B | 4.92% |
| 2008-06-30 | $0.13B | $2.92B | 4.38% |
| 2008-03-31 | $0.14B | $2.79B | 4.95% |
| 2007-12-31 | $0.13B | $2.64B | 5.03% |
| 2007-09-30 | $0.12B | $2.53B | 4.82% |
| 2007-06-30 | $0.12B | $2.51B | 4.82% |
| 2007-03-31 | $0.11B | $2.51B | 4.42% |
| 2006-12-31 | $0.12B | $2.51B | 4.78% |
| 2006-09-30 | $0.27B | $2.56B | 10.40% |
| 2006-06-30 | $0.27B | $2.56B | 10.49% |
| 2006-03-31 | $0.27B | $2.54B | 10.73% |
| 2005-12-31 | $0.27B | $2.56B | 10.50% |
| 2005-09-30 | $0.12B | $2.53B | 4.70% |
| 2005-06-30 | $0.11B | $2.55B | 4.36% |
| 2005-03-31 | $0.10B | $2.56B | 4.02% |
| 2004-12-31 | $0.10B | $2.56B | 3.75% |
| 2004-09-30 | $0.09B | $2.57B | 3.35% |
| 2004-06-30 | $0.08B | $2.58B | 2.95% |
| 2004-03-31 | $0.06B | $2.63B | 2.39% |
| 2003-12-31 | $0.05B | $2.68B | 1.94% |
| 2003-09-30 | $0.02B | $2.74B | 0.77% |
| 2003-06-30 | $0.01B | $2.74B | 0.51% |
| 2003-03-31 | $0.00B | $2.72B | -0.11% |
| 2002-12-31 | $-0.15B | $2.76B | -5.51% |
| 2002-09-30 | $-0.20B | $2.79B | -7.12% |
| 2002-06-30 | $-0.18B | $2.71B | -6.46% |
| 2002-03-31 | $-0.14B | $2.60B | -5.27% |
| 2001-12-31 | $0.03B | $2.45B | 1.35% |
| 2001-09-30 | $0.12B | $2.25B | 5.46% |
| 2001-06-30 | $0.09B | $2.25B | 4.18% |
| 2001-03-31 | $0.10B | $2.13B | 4.74% |
| 2000-12-31 | $0.09B | $2.00B | 4.71% |
| 2000-09-30 | $0.09B | $1.88B | 4.63% |
| 2000-06-30 | $0.19B | $1.73B | 10.86% |
| 2000-03-31 | $0.16B | $1.70B | 9.20% |
| 1999-12-31 | $0.15B | $1.55B | 9.94% |
| 1999-09-30 | $0.14B | $1.42B | 9.95% |
| 1999-06-30 | $0.05B | $1.23B | 4.30% |
| 1999-03-31 | $0.08B | $1.05B | 7.71% |
| 1998-12-31 | $0.10B | $0.97B | 10.37% |
| 1998-09-30 | $0.10B | $0.89B | 11.51% |
| 1998-06-30 | $0.10B | $0.86B | 11.90% |
| 1998-03-31 | $0.06B | $0.83B | 6.99% |
| 1997-12-31 | $0.03B | $0.82B | 4.17% |
| 1997-09-30 | $0.03B | $0.81B | 3.56% |
| 1997-06-30 | $0.03B | $0.82B | 3.65% |
| 1997-03-31 | $0.06B | $0.83B | 7.02% |
| 1996-12-31 | $0.06B | $0.83B | 7.34% |
| 1996-09-30 | $0.07B | $0.83B | 8.11% |
| 1996-06-30 | $0.07B | $0.81B | 8.24% |
| 1996-03-31 | $0.07B | $0.80B | 8.36% |
| 1995-12-31 | $0.07B | $0.80B | 8.53% |
| 1995-09-30 | $0.06B | $0.80B | 7.30% |
| 1995-06-30 | $-0.01B | $0.80B | -0.76% |
| 1995-03-31 | $-0.01B | $0.80B | -0.75% |
| 1994-12-31 | $-0.01B | $0.79B | -0.76% |
| 1994-09-30 | $0.01B | $0.78B | 0.77% |
| 1994-06-30 | $0.07B | $0.78B | 8.85% |
| 1994-03-31 | $0.07B | $0.78B | 9.46% |
| 1993-12-31 | $0.06B | $0.78B | 7.59% |
| 1993-09-30 | $0.06B | $0.77B | 7.89% |
| 1993-06-30 | $0.07B | $0.76B | 8.90% |
| 1993-03-31 | $0.07B | $0.75B | 9.18% |
| 1992-12-31 | $0.09B | $0.74B | 11.84% |
| 1992-09-30 | $0.09B | $0.73B | 11.78% |
| 1992-06-30 | $0.09B | $0.71B | 12.08% |
| 1992-03-31 | $0.08B | $0.69B | 12.23% |
| 1991-12-31 | $0.08B | $0.68B | 12.14% |
| 1991-09-30 | $0.08B | $0.67B | 11.80% |
| 1991-06-30 | $0.08B | $0.67B | 11.26% |
| 1991-03-31 | $0.08B | $0.66B | 11.30% |
| 1990-12-31 | $0.07B | $0.65B | 11.32% |
| 1990-09-30 | $0.07B | $0.65B | 11.15% |
| 1990-06-30 | $0.07B | $0.62B | 11.33% |
| 1990-03-31 | $0.07B | $0.59B | 11.34% |
| 1989-12-31 | $0.07B | $0.57B | 12.09% |
| 1989-09-30 | $0.07B | $0.55B | 13.41% |
| 1989-06-30 | $0.07B | $0.53B | 13.31% |
| 1989-03-31 | $0.07B | $0.53B | 13.58% |
| 1988-12-31 | $0.07B | $0.52B | 13.22% |
| 1988-09-30 | $0.06B | $0.52B | 11.87% |
| 1988-06-30 | $0.06B | $0.52B | 11.98% |
| 1988-03-31 | $0.06B | $0.51B | 11.60% |
| 1987-12-31 | $0.06B | $0.49B | 11.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.007B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.899B | 26.08 |
| CVS Health (CVS) | United States | $113.624B | 11.33 |
| HCA Healthcare (HCA) | United States | $92.600B | 14.40 |
| Elevance Health (ELV) | United States | $89.122B | 13.98 |
| Cencora (COR) | United States | $58.924B | 18.00 |
| Natera (NTRA) | United States | $53.245B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.010B | 18.34 |
| Viatris (VTRS) | United States | $19.469B | 6.73 |
| Medpace Holdings (MEDP) | United States | $17.091B | 35.89 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.888B | 0.00 |
| DiDi Global (DIDIY) | China | $16.776B | 184.00 |
| Solventum (SOLV) | United States | $15.123B | 12.51 |
| Charles River Laboratories (CRL) | United States | $13.274B | 28.09 |
| ICON (ICLR) | Ireland | $12.565B | 17.08 |
| BrightSpring Health Services (BTSG) | United States | $11.235B | 38.63 |
| Avantor (AVTR) | United States | $10.497B | 18.93 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.472B | 83.28 |
| HealthEquity (HQY) | United States | $7.870B | 25.64 |
| Sonic Healthcare (SKHHY) | Australia | $6.732B | 0.00 |
| PACS (PACS) | United States | $6.666B | 22.40 |
| GETINGE (GNGBY) | Sweden | $6.516B | 18.40 |
| CochLear (CHEOY) | Australia | $6.200B | 0.00 |
| MiniMed (MMED) | United States | $6.131B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.021B | 22.77 |
| Sotera Health (SHC) | United States | $5.345B | 22.03 |
| Concentras Parent (CON) | United States | $4.523B | 22.31 |
| Organon (OGN) | United States | $3.593B | 4.56 |
| GeneDx Holdings (WGS) | United States | $3.015B | 280.83 |
| CareDx (CDNA) | United States | $2.785B | 316.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.107B | 12.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.103B | 0.00 |
| Progyny (PGNY) | United States | $2.082B | 29.49 |
| Establishment Labs Holdings (ESTA) | United States | $2.065B | 0.00 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $2.011B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.839B | 0.00 |
| Freenome (FRNM) | United States | $1.838B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.735B | 66.25 |
| Alignment Healthcare (ALHC) | United States | $1.732B | 43.95 |
| Agilon Health (AGL) | United States | $1.497B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Ardent Health (ARDT) | United States | $1.478B | 8.45 |
| Nutex Health (NUTX) | United States | $1.430B | 8.20 |
| Omada Health (OMDA) | United States | $1.251B | 255.38 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.158B | 22.53 |
| Teladoc Health (TDOC) | United States | $1.145B | 0.00 |
| CryoPort (CYRX) | United States | $0.862B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.677B | 0.00 |
| Forward Industries (FWDI) | United States | $0.569B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 10.11 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.378B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.48 |
| Biodesix (BDSX) | United States | $0.308B | 0.00 |
| Embecta (EMBC) | United States | $0.300B | 2.59 |
| So-Young (SY) | China | $0.279B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.101B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.082B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.073B | 8.67 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.036B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |